Ketek telithromycin: Phase III data; marketed

Aventis S.A. (AVE), Strasbourg, France
Product: Ketek telithromycin
Business: Infectious diseases
Therapeutic category:

Read the full 132 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE